Goldman Sachs’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Sell |
180,189
-169,914
| -49% | -$154K | ﹤0.01% | 4780 |
|
|
2025
Q1 | $158K | Sell |
350,103
-34,963
| -9% | -$15.8K | ﹤0.01% | 4722 |
|
|
2024
Q4 | $193K | Buy |
385,066
+140,842
| +58% | +$70.8K | ﹤0.01% | 4672 |
|
|
2024
Q3 | $221K | Buy |
244,224
+79,640
| +48% | +$72.1K | ﹤0.01% | 4461 |
|
|
2024
Q2 | $164K | Buy |
164,584
+138,030
| +520% | +$138K | ﹤0.01% | 4411 |
|
|
2024
Q1 | $39.3K | Sell |
26,554
-10,893
| -29% | -$16.1K | ﹤0.01% | 4556 |
|
|
2023
Q4 | $40.8K | Buy |
37,447
+7,557
| +25% | +$8.24K | ﹤0.01% | 4564 |
|
|
2023
Q3 | $35.3K | Buy |
29,890
+3,370
| +13% | +$3.98K | ﹤0.01% | 4517 |
|
|
2023
Q2 | $37.4K | Sell |
26,520
-253,249
| -91% | -$357K | ﹤0.01% | 4702 |
|
|
2023
Q1 | $420K | Buy |
279,769
+265,690
| +1,887% | +$399K | ﹤0.01% | 4169 |
|
|
2022
Q4 | $16.5K | Sell |
14,079
-1,394
| -9% | -$1.63K | ﹤0.01% | 4913 |
|
|
2022
Q3 | $17K | Sell |
15,473
-64,696
| -81% | -$71.1K | ﹤0.01% | 5194 |
|
|
2022
Q2 | $127K | Sell |
80,169
-47,263
| -37% | -$74.9K | ﹤0.01% | 5047 |
|
|
2022
Q1 | $196K | Buy |
127,432
+28,773
| +29% | +$44.3K | ﹤0.01% | 5108 |
|
|
2021
Q4 | $242K | Buy |
98,659
+1,588
| +2% | +$3.9K | ﹤0.01% | 4892 |
|
|
2021
Q3 | $245K | Buy |
97,071
+83,697
| +626% | +$211K | ﹤0.01% | 4770 |
|
|
2021
Q2 | $38K | Sell |
13,374
-185,264
| -93% | -$526K | ﹤0.01% | 5271 |
|
|
2021
Q1 | $467K | Buy |
+198,638
| New | +$467K | ﹤0.01% | 4408 |
|
|
2020
Q3 | – | Sell |
-120,899
| Closed | -$105K | – | 4506 |
|
|
2020
Q2 | $105K | Buy |
120,899
+55,189
| +84% | +$47.9K | ﹤0.01% | 4170 |
|
|
2020
Q1 | $54K | Sell |
65,710
-33,123
| -34% | -$27.2K | ﹤0.01% | 4263 |
|
|
2019
Q4 | $88K | Buy |
98,833
+53,721
| +119% | +$47.8K | ﹤0.01% | 4145 |
|
|
2019
Q3 | $44K | Buy |
45,112
+10,084
| +29% | +$9.84K | ﹤0.01% | 4138 |
|
|
2019
Q2 | $39K | Sell |
35,028
-7,438
| -18% | -$8.28K | ﹤0.01% | 4102 |
|
|
2019
Q1 | $56K | Sell |
42,466
-28,799
| -40% | -$38K | ﹤0.01% | 4076 |
|
|
2018
Q4 | $65K | Sell |
71,265
-695
| -1% | -$634 | ﹤0.01% | 3948 |
|
|
2018
Q3 | $148K | Sell |
71,960
-514
| -0.7% | -$1.06K | ﹤0.01% | 3879 |
|
|
2018
Q2 | $130K | Buy |
72,474
+28,094
| +63% | +$50.4K | ﹤0.01% | 3969 |
|
|
2018
Q1 | $104K | Buy |
44,380
+10,252
| +30% | +$24K | ﹤0.01% | 4010 |
|
|
2017
Q4 | $64K | Sell |
34,128
-12,410
| -27% | -$23.3K | ﹤0.01% | 4019 |
|
|
2017
Q3 | $116K | Buy |
46,538
+2,047
| +5% | +$5.1K | ﹤0.01% | 4009 |
|
|
2017
Q2 | $123K | Sell |
44,491
-64,718
| -59% | -$179K | ﹤0.01% | 4099 |
|
|
2017
Q1 | $330K | Buy |
109,209
+90,585
| +486% | +$274K | ﹤0.01% | 3730 |
|
|
2016
Q4 | $59K | Buy |
18,624
+1,110
| +6% | +$3.52K | ﹤0.01% | 4211 |
|
|
2016
Q3 | $60K | Sell |
17,514
-7,639
| -30% | -$26.2K | ﹤0.01% | 4275 |
|
|
2016
Q2 | $57K | Buy |
25,153
+7,835
| +45% | +$17.8K | ﹤0.01% | 4252 |
|
|
2016
Q1 | $43K | Buy |
+17,318
| New | +$43K | ﹤0.01% | 4249 |
|
|
2015
Q4 | – | Sell |
-15,009
| Closed | -$36K | – | 4546 |
|
|
2015
Q3 | $36K | Sell |
15,009
-39,534
| -72% | -$94.8K | ﹤0.01% | 4390 |
|
|
2015
Q2 | $160K | Buy |
54,543
+37,720
| +224% | +$111K | ﹤0.01% | 4124 |
|
|
2015
Q1 | $67K | Sell |
16,823
-1,697
| -9% | -$6.76K | ﹤0.01% | 4234 |
|
|
2014
Q4 | $56K | Buy |
+18,520
| New | +$56K | ﹤0.01% | 4362 |
|
|
2014
Q3 | – | Sell |
-14,889
| Closed | -$37K | – | 4550 |
|
|
2014
Q2 | $37K | Sell |
14,889
-70,683
| -83% | -$176K | ﹤0.01% | 4310 |
|
|
2014
Q1 | $227K | Buy |
85,572
+52,116
| +156% | +$138K | ﹤0.01% | 3853 |
|
|
2013
Q4 | $97K | Buy |
33,456
+9,240
| +38% | +$26.8K | ﹤0.01% | 4093 |
|
|
2013
Q3 | $74K | Buy |
24,216
+2,862
| +13% | +$8.75K | ﹤0.01% | 4059 |
|
|
2013
Q2 | $68K | Buy |
+21,354
| New | +$68K | ﹤0.01% | 3854 |
|